Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Trading at .0002 what happened to 20.00 ? Savage and Gold ?

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Jan 09, 2024 12:25pm

415 Views

Post# 35817570

Trading at .0002 what happened to 20.00 ? Savage and Gold ?

So a million shares are now worth 200.00 , thanks for all the great advice pumpers and name callers to average down, don't let those shorters convince to sell your shares when they were at .40 cents just before the wheels feel off the wagon in April 2021.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter